Vanguard Group Inc Organogenesis Holdings Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,431,414 shares of ORGO stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,431,414
Previous 3,589,796 23.44%
Holding current value
$12.1 Million
Previous $11.5 Million 66.65%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$2.89 - $6.21 $2.43 Million - $5.23 Million
841,618 Added 23.44%
4,431,414 $19.1 Million
Q4 2024

Feb 11, 2025
SELL
$2.77 - $4.43 $228,901 - $366,077
-82,636 Reduced 2.25%
3,589,796 $11.5 Million
Q3 2024

Nov 13, 2024
BUY
$2.42 - $3.24 $265,527 - $355,499
109,722 Added 3.08%
3,672,432 $10.5 Million
Q2 2024

Aug 13, 2024
BUY
$2.28 - $3.03 $62,497 - $83,055
27,411 Added 0.78%
3,562,710 $9.98 Million
Q1 2024

May 10, 2024
SELL
$2.61 - $4.49 $4.76 Million - $8.2 Million
-1,825,428 Reduced 34.05%
3,535,299 $10 Million
Q4 2023

Feb 14, 2024
BUY
$1.97 - $4.21 $3.28 Million - $7.01 Million
1,665,088 Added 45.06%
5,360,727 $21.9 Million
Q3 2023

Nov 14, 2023
BUY
$2.34 - $4.43 $161,916 - $306,533
69,195 Added 1.91%
3,695,639 $11.8 Million
Q2 2023

Aug 14, 2023
SELL
$1.9 - $4.3 $167,241 - $378,494
-88,022 Reduced 2.37%
3,626,444 $12 Million
Q1 2023

May 15, 2023
SELL
$1.89 - $2.93 $2.09 Million - $3.24 Million
-1,105,755 Reduced 22.94%
3,714,466 $7.91 Million
Q4 2022

Feb 10, 2023
BUY
$2.48 - $3.43 $844,648 - $1.17 Million
340,584 Added 7.6%
4,820,221 $13 Million
Q3 2022

Nov 14, 2022
BUY
$3.14 - $6.43 $862,404 - $1.77 Million
274,651 Added 6.53%
4,479,637 $14.5 Million
Q2 2022

Aug 12, 2022
SELL
$4.74 - $8.15 $1.9 Million - $3.26 Million
-400,271 Reduced 8.69%
4,204,986 $20.5 Million
Q1 2022

May 13, 2022
BUY
$6.47 - $9.57 $1.96 Million - $2.9 Million
303,243 Added 7.05%
4,605,257 $35.1 Million
Q4 2021

Feb 14, 2022
BUY
$9.02 - $13.5 $1.02 Million - $1.53 Million
112,990 Added 2.7%
4,302,014 $39.8 Million
Q3 2021

Nov 12, 2021
BUY
$13.71 - $17.18 $18.7 Million - $23.5 Million
1,365,400 Added 48.36%
4,189,024 $59.7 Million
Q2 2021

Aug 13, 2021
BUY
$14.92 - $23.23 $42.1 Million - $65.6 Million
2,823,624 New
2,823,624 $46.9 Million

Others Institutions Holding ORGO

# of Institutions
142
Shares Held
64.5M
Call Options Held
15.3K
Put Options Held
925
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $359M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email